US 12,156,906 B2
Immunologically active fragments of toxoplasma gondii
Laurence David Sibley, St. Louis, MO (US); Iti Saraav, St. Louis, MO (US); Qiuling Wang, St. Louis, MO (US); and Mary Savari Dhason, St. Louis, MO (US)
Assigned to Washington University, St. Louis, MO (US)
Appl. No. 17/636,743
Filed by Washington University, St. Louis, MO (US)
PCT Filed Aug. 19, 2020, PCT No. PCT/US2020/047048
§ 371(c)(1), (2) Date Feb. 18, 2022,
PCT Pub. No. WO2021/034963, PCT Pub. Date Feb. 25, 2021.
Claims priority of provisional application 62/888,803, filed on Aug. 19, 2019.
Prior Publication US 2022/0288174 A1, Sep. 15, 2022
Int. Cl. A61K 39/002 (2006.01); A61K 39/00 (2006.01); A61P 33/02 (2006.01); C07K 14/45 (2006.01); C07K 16/20 (2006.01)
CPC A61K 39/002 (2013.01) [A61P 33/02 (2018.01); C07K 14/45 (2013.01); C07K 16/20 (2013.01); A61K 2039/54 (2013.01); A61K 2039/57 (2013.01)] 15 Claims
 
1. A composition comprising an antigen consisting of the amino acid sequence set forth in SEQ ID NO: 3.